Junk DNA enhances pEI-based non-viral gene delivery.

E.V.B. van Gaal, R.S. Oosting, W.E. Hennink, D.J.A. Crommelin, E. Mastrobattista

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Gene therapy aims at delivering exogenous DNA into the nuclei of target cells to establish expression of a therapeutic protein. Non-viral gene delivery is examined as a safer alternative to viral approaches, but is presently characterized by a low efficiency. In the past years several non-viral delivery strategies have been developed, including cationic polymer-based delivery. One of the most described and most active polymers is linear pEI. This study addresses questions regarding formulating highly efficient pEI-based polyplexes. By mixing reporter plasmid DNA with non-coding junk DNA it was shown that the amount of reporter plasmid can be significantly decreased in linear pEI-based transfection while maintaining transfer activity. Junk DNA maximally exerts its function when co-delivered with active DNA within the same pEI complexes rather than upon co-delivery of distinct junk DNA/pEI and active DNA/pEI complexes. We conclude that not the total amount of active DNA, but rather the total amount of active DNA-containing particles is the limiting factor in pEI-mediated transfection.
Original languageUndefined/Unknown
Pages (from-to)76-83
Number of pages8
JournalInternational Journal of Pharmaceutics
Volume390
Issue number1
Publication statusPublished - 2010

Keywords

  • Medical technology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Pharmacology

Cite this